250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care Angel Investors in Israel in July 2025

A list of 50 angel investors that invest in Health care startups based in Israel. We rank investors based on the number of investments they made in Health care companies from Israel. We update this investor list every month.

Top 50 Health Care Angel Investors in Israel in July 2025

Investor Health Care Israel investments
Marius Nacht 5
Ran Tuttnauer 3
Howard Morgan 3
Zohar Gilon 3
Shimon Eckhouse 2
Assaf Wand 2
Mazal CB 2
Moshe Gaon 2
Yaron Samid 2
Shimon Eckhouse 2
Ron C 2
Shmuel Cabilly 2
Yehuda Zisapel 2
Oren Dobronsky 2
Prof. Rafael Beyar 2
Dov Moran 2
Rafi Benary 1
Rick Klausner 1
David Agus 1
Romain Afflelou 1
Mandeep Singh 1
Amiad Solomon 1
Noam Solomon 1
Gigi Levy Weiss 1
Bradley M. Bloom 1
Yasmin Lukatz 1
Raoul Stein 1
Nir Greenberg 1
Lyndon Babtiste 1
Edward Lando 1
Moshe Shoham 1
Alan Patricof 1
Robert Nelsen 1
Lily Sarafan 1
Brock Weatherup 1
Lewis Pell 1
Shahar Tzafrir 1
Ron Sabar 1
Nir Kalkstein 1
Mori Arkin 1
Ariel Yaar 1
Sacha Levy 1
Larry Ellison 1
Zohar Zisapel 1
Nadav Lurie 1
Anne Wojcicki 1
Tamara Minick-Scokalo 1
Avishai Abrahami 1
Oren Zeev 1
Eyal Gura 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Marius Nacht Angel · Tel Aviv-yafo, Tel Aviv, Israel
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more
Investment focus
  • Artificial Intelligence, Machine Learning, Health Care
  • Series A, Funding Round, Seed
  • Israel, United States, Germany
Portfolio highlights
  • CPTx — At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
  • Wisdo Health — Wisdo is an AI-powered Social Health platform harnessing the power of data and meaningful connections to improve health.
  • WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
Ran Tuttnauer Angel
Ran Tuttnauer
Show more
Investment focus
  • Health Care, Big Data, Medical Device
  • Seed, Series A
  • Israel, Canada, United States
Portfolio highlights
  • Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
  • Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
  • Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders.
Howard Morgan Angel · New York, New York, United States · 3 investments in the past 12 months
Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley. Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal. Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences. Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • United States, Israel, India
Portfolio highlights
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • HATCH — HATCH is the first of its kind Giving Intelligence Platform. An AI-powered portal for Fundraisers, Marketers and Volunteers to streamline and Maximize their impact. A new home for a new world of giving!
  • Garden — Garden helps lawyers and companies automate invention harvesting, generate novel patents, and analyze infringements in a couple clicks.
Zohar Gilon Angel
Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994.
Show more
Investment focus
  • Software, Internet, Health Care
  • Seed, Series A, Series B
  • Israel, United States
Portfolio highlights
  • CADY — CADY utilizes AI technology to automate the analysis of electrical schematics
  • Loora — Unlock your full potential with Loora, your very own AI English tutor. Engage in real conversations with Loora anytime, anywhere, and on any topic!
  • Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Shimon Eckhouse Angel
Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology.
Show more
Investment focus
  • Health Care, Medical Device, Medical
  • Series B, Series C, Funding Round
  • Israel
Portfolio highlights
  • Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
  • Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
  • RealView Imaging — RealView Imaging is pioneering the field of interactive live holography, creating a new dimension for Augmented Reality applications.
Assaf Wand Angel · Palo Alto, California, United States
Assaf Wand is the Founder and Executive Chairman of Hippo Insurance. He previously worked at Sabi (Sold to Urbio) as a Founder and CEO. Assaf Wand attended Reichman University (IDC Herzliya).
Show more
Investment focus
  • Insurance, Health Care, Information Technology
  • Seed, Series A, Series B
  • United States, Brazil, France
Portfolio highlights
  • RoadFlex — Start saving more on fuel. Competitive discounts. No PG needed to apply. Apply now and get your new fuel card approved in 1 day.
  • Fairmatic — Powered by data and AI, focused on rewarding fleet safety with savings. Finally, a smarter insurance option designed to put fleets in control.
  • Modern Life — Modern Life is a tech-enabled life insurance brokerage. With a focus on empowering advisors, Modern Life offers advanced technology solutions to digitally streamline advisors’ practices and expert brokerage support. With Modern Life, advisors nationwide can compare quotes from top carriers in minutes, perform data-driven underwriting assessments,manage clients from an integrated dashboard, and receive comprehensive deal support.
Mazal CB Angel
Mazal CB
Show more
Investment focus
  • Health Care, Therapeutics, Medical Device
  • Seed, Pre-Seed
  • Israel
Portfolio highlights
  • DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Moshe Gaon Angel
Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies.
Show more
Investment focus
  • Advertising, Association, Social Media Marketing
  • Seed, Series A, Convertible Note
  • Israel, United States
Portfolio highlights
  • Apester — Supercharge your marketing and funnel with interactive content experiences that generate more leads, engage and convert users, and boost retention
  • Yoocan — Yoocan is a global community for people with disabilities and their families, discover empowering stories, find support, and connect with a world that understands you.
  • IndieFlow — IndieFlow developed a workflow management platform for the music industry. The platform provides a centralized platform to manage music industry workflows and streamline the major building blocks of an artist’s career. It enables users to manage creative projects, distribute to streaming platforms, collect roylaties, register music with royaltycollection societies, promote music, book gigs, receive payments and more.
Yaron Samid Angel · Ramat Hasharon, Tel Aviv, Israel
Yaron Samid is an Israeli-American technology entrepreneur, investor, and startup community builder. Yaron is the founder of TechAviv, the 3K-member global Israeli startup founders club, and is the managing partner of TechAviv Founder Partners, a pre-seed venture fund, backed and powered by over 100 of the world’s most successful company builders.Previously, Yaron was the founder and CEO at BillGuard (Acq. by Prosper), founder & CPO at Pando (Acq. by Microsoft), and a founding board director at CloudLock (Acq. by Cisco) and Pond5.Yaron lives in Tel Aviv with his family and is a regular guest lecturer at Stanford and Columbia Business School. He attended Technion - Israel Institute of Technology and the University of Maryland.
Show more
Investment focus
  • Software, Apps, Machine Learning
  • Seed, Pre-Seed, Series A
  • United States, Israel, Brazil
Portfolio highlights
  • bxblue — bxblue is a marketplace for personal loans in Brazil explicitly targeting pensioners and Government workers because they can they take loans secured by their guaranteed income. Because of that banks can deduct the payment directly from the paycheck, leading to an apr 10x lower than credit cards. Payroll secured loans are the most affordablepersonal loan in Brazil, and they represent 60% of the personal loans in the country. It is a 40bn dollar/year marke, completely offline. We are taking this entire market online.
  • Emedgene — Applying machine learning to genomics. Accelerate NGS data analysis and automate variant classification with evidence curated from the literature. From sample to report.
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Shimon Eckhouse Angel
Shimon Eckhouse
Show more
Investment focus
  • Medical, Biotechnology, Fitness
  • Seed, Funding Round
  • Israel
Portfolio highlights
  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Epitomee Medical — Epitomee develops paradigm-shifting ingestibledevices that deploy targeted therapies along the GI tract
Ron C Angel
Ron C
Show more
Investment focus
  • Health Care, Therapeutics, Medical Device
  • Seed, Pre-Seed
  • Israel
Portfolio highlights
  • DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
Shmuel Cabilly Angel · Rehovot, HaMerkaz, Israel
Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more.
Show more
Investment focus
  • Health Care, Medical, Artificial Intelligence
  • Funding Round, Series B, Series C
  • Israel, United States
Portfolio highlights
  • Treato — Treato automatically collects the massive amount of patient-written health experiences from blogs and forums and, with advanced Natural Language Processing (NLP), extracts relevant information, connects the dots and creates the big picture of what people say about their medications and conditions.Treato's big data analytics are availablein a consumer site and as an in-depth service for pharmaceutical marketers.Treato's Consumer site (
  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Yehuda Zisapel Angel
Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products.
Show more
Investment focus
  • Medical Device, Medical, Health Care
  • Funding Round, Series A, Seed
  • Israel
Portfolio highlights
  • Carteav — Autonomous Low Speed Vehicle
  • Rewire — Secure financial services designed to help migrants make cross-border money transfers. Rewire offers great rates, fast delivery, multilingual customer support
  • Laminate Medical — Laminate Medical Technologies is developing a new, external support device for AV fistulas, to be implanted during the fistula creation surgical procedure. The VasQ Device alleviates wall tension and regulates fistula geometry where an undesired narrowing of the vein and/or frequent blockages of the blood vessels may occur during the firstyear. Use of Laminate Medical Technology’s novel device aims to drive a change in the hemodialysis vascular access treatment paradigm and bring about a significant reduction in the annual fistula failure rate, thereby reducing kidney-failure related complications, re-interventions, and the cost burden of vascular access complications.
Oren Dobronsky Angel · Palo Alto, California, United States
Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :)
Show more
Investment focus
  • FinTech, Software, Customer Service
  • Seed, Series A, Angel
  • United States, Israel
Portfolio highlights
  • Linguana — Linguana builds and monetizes your fully localized YouTube channels in new languages to reach new audiences across the globe and monetize them.
  • Openbase — Find and compare the best open-source packages in hundreds of categories - withpowerful metrics and user reviews
  • Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
Prof. Rafael Beyar Angel · Haifa, Hefa, Israel
Prof. Rafael Beyar
Show more
Investment focus
  • Medical, Medical Device, Machine Learning
  • Seed, Series A
  • Israel
Portfolio highlights
  • MedHub-AI — MedHub-AI develops deep-learning video analysis algorithms that provide accurate diagnostic insights and practical guidance for physicians. Users can incorporate its algorithm into medical video systems to improve the decision-making process for cardiologists and other physicians. Its technology uses multiple technological and big-data processingmethods designed to handle a massive amount of clinical data, both visual and textual. It designs its algorithms to improve physicians' performance and shorten procedure times by providing a multilayered automated system that is implemented from diagnosis to practical procedural guidance and documentation. It currently offers solutions for the cardiology and gastroenterology markets.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
Dov Moran Angel · Kfar Saba, HaMerkaz, Israel
Dov Moran is the Managing Partner of Grove Ventures. He previously worked at modu as the Founder, Chairman, and CEO. Dov Moran attended Technion.
Show more
Investment focus
  • Semiconductor, Hardware, Health Care
  • Series A, Seed, Series B
  • Israel, United States
Portfolio highlights
  • Rapid — RapidAPI is an API Hub that enables over 3 million developers to find, manage, and connect to APIs. RapidAPI lets developers manage all API integrations from one place and gives real-time performance metrics. RapidAPI was founded in 2014 and is headquartered in San Francisco, California.
  • Triple Jump Medical — Triple Jump Medical is a developer of an insulin pump intended to treat diabetic patients.
  • Sensible Medical Innovations — Sensible Medical Innovation Ltd. is introducing a breakthrough sensing and monitoring technology providing actionable and accurate data for guiding the management and treatment of several chronic medical conditions representing today’s biggest burden on US and worldwide healthcare budgets.
Rafi Benary Angel
Rafi Benary is the Co-founder at Innoventric and he holds a Masters’ degree from the New York University in Material Science and a Mechanical Engineering. He is an entrepreneur of 4 start-up companies, bringing them from inception to clinical stage through effective planning and execution.
Show more
Investment focus
  • Medical, Medical Device, Health Diagnostics
  • Pre-Seed
  • Israel
Portfolio highlights
  • Althea Medical — Althea Medical is a creator of catheter devices for the treatment of patients with sub- or major pulmonary emboli. The company is developing a catheter-based solution for treating patients suffering from massive and sub-massive Pulmonary Embolism (PE). Althea Medical was established in 2020 in Tel Aviv, Israel.
Rick Klausner Angel · San Francisco Bay Area, California, United States
Rick Klausner is a Chief Executive Officer at Lyell Immunopharma.
Show more
Investment focus
  • Biotechnology, Therapeutics, Life Science
  • Series A, Series B, Series E
  • United States, Israel, United Kingdom
Portfolio highlights
  • bit.bio — Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. Their mission is coding cells for health. To do so, we apply the principles of computation to biology. Bit.bio's current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. Thishas the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by the human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modeling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious, and driven by a common purpose.
  • Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
  • LifeMine Therapeutics — What if the solutions to the greatest unsolved medical problems of our time had already been evolved in nature, hiding in plain sight as molecules waiting to be mined? What if revolutionary discoveries in emerging scientific fields from gigascale DNA sequencing to artificial intelligence and synthetic biology had advanced, such that we finally had a way to mine the biosphere and bring transformative new medicines to patients in need? Our answers to these questions drive the passion and mission at LifeMine Therapeutics.
David Agus Angel · Beverly Hills, California, United States
David Agus is an American physician and a New York Times bestselling author. He is a Professor of Medicine and Engineering at the University of Southern California. He is co-founder of Navigenics, a personalized medicine company and Applied Proteomics, as well as a CBS News contributor.
Show more
Investment focus
  • Health Care, Health Diagnostics, Artificial Intelligence
  • Series A
  • Israel
Portfolio highlights
  • Imagene AI — Imagene AI is democratizing precision medicine with multi-modal foundation models and an end-to-end OI Suite. Our living intelligence engine integrates imaging, molecular, and clinical data to make every trial more responsive, every insight more actionable, and every patient journey more personalized.
Romain Afflelou Angel · London, England, United Kingdom
Romain spearheaded the digital strategy of Alain Afflelou Group before becoming an investor in numerous start-ups. He uses his fine-tuned analysis skills to support and invest in innovative start-ups. In addition to being a major shareholder and Co founder of Cosmo Connected a French start-up specialized in connected objects related to security andmobility.Romain is Director and Board member of Multiwave Technologies /develops breakthrough metamaterial technologies to improve people's lives.Serial investor in +50Tech companies6over6 (Acquired by 1-800 contacts) Cityscoot Clay Inc VR Cowboy Bike Epicery Everoad (Ex Convargo) Fithouse Fré Skincare Fokoya Guillotine Vodka Klassroom Laminate Technologies MeetFabric Molotov TV Multiwave Technologies Nestor Octopus Officeriders Onoff telecom Pledg Quiqup Universal Standard Shapr Spendesk Zipdrug...(Acquire by Anthem Pharmacy)
Show more
Investment focus
  • Health Care, FinTech, Software
  • Seed, Series A, Pre-Seed
  • France, United States, Israel
Portfolio highlights
  • Cashbee — Cashbee is a mobile application to helps save money with budget analysis tools based on artificial intelligence. They wish to help the French to save better and more, and to provide the technological means to do this in the simplest possible way, without having to change banks. The Cashbee App allows you to put money aside with a simple swipe onyour smartphone. They alert you every time when they think you can put some more cash aside.
  • Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
  • Kubo Labs — Kubo Labs provides a suite of products to simplify your experience with Kubernetes.
Mandeep Singh Angel · London, England, United Kingdom · 7 investments in the past 12 months
Mandeep Singh is an Angel investor at multiple firms. He previously was the founding CEO at Trouva. Mandeep Singh studied Physics at the University of Cambridge.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Pre-Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Stackfix — Stackfix operates as a software comparison platform.
  • Prior Labs — Prior Labs develops Tabular Foundation Models (TFMs) like TabPFN to solve AI's structured data challenge, enabling native understanding & boosting ML performance.
  • Bluebook — self-driving accounting
Amiad Solomon Angel · Tel Aviv, Tel Aviv, Israel
Amiad Solomon is the CEO and Founder of HQ. He previously worked at Komoona as a Founder and Chairman.
Show more
Investment focus
  • Nutrition, Food Processing, Loyalty Programs
  • Seed, Pre-Seed, Series A
  • Israel, United States
Portfolio highlights
  • Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
  • Snowmate — Snowmate's disruptive technology finds backend bugs fully automatically and at the earliest stages of the development cycle - no AI, no magic tricks, but pure deep tech only.
  • ANYBODIES — Anybodies is the first enterprise customer engagement platform for creating NFT based loyalty programs for creators, brands and enterprises.
Noam Solomon Angel · Tel Aviv-yafo, Tel Aviv, Israel
Noam Soloman is the CEO and co-founder at Immunai, the first and only company to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out thousands of immune cells and their functions, building the largest proprietary data setin the world for clinical immunological data. Prior to co-founding Immunai, Noam had a dual career in both the industry and academia. Noam is a double Ph.D., and served as a post-doctoral researcher in the Mathematics department at MIT, and in the center of mathematical sciences and applications at Harvard University. In his research, he developed and applied tools from algebra and Algebraic Geometry in the study of classical problems in combinatorics. Noam also worked as an algorithms developer in the Israeli defense forces and subsequently as a data scientist, consultant and head of data science in several hi-tech companies in Israel.
Show more
Investment focus
  • Software, Wellness, Health Care
  • Seed
  • Israel
Portfolio highlights
  • NeuraLight — Transforming clinical development, diagnostics, and precision medicine in neurology with AI. We are building an AI-driven platform to accelerate and improve drug development and patient monitoring, as well as introduce precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone.
Gigi Levy Weiss Angel
Gigi Levy Weiss is the General Partner at NFX. He attended Tel Aviv University and the Finance Department - Kellogg School of Management.
Show more
Investment focus
  • Software, Artificial Intelligence, SaaS
  • Seed, Series A, Series B
  • Israel, United States, United Kingdom
Portfolio highlights
  • Shamaym — Continuous Improvement Platform helps teams get better every day and drive better outcomes in product development, sales, support, and more.
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
  • Diagnostic Robotics — Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
Bradley M. Bloom Angel · Boston, Massachusetts, United States
Bradley M. Bloom is the Managing Director at Berkshire Partners.
Show more
Investment focus
  • Artificial Intelligence, Food and Beverage, Sports
  • Funding Round, Seed, Series A
  • Israel, United States
Portfolio highlights
  • Perch — Perch brings velocity based training into the 21st century. No strings. No wearables. Learn more about how Perch enables VBT and weight room technology!
  • Diagnostic Robotics — Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.
  • AUI™ (Augmented Intelligence) Inc. — Apollo is a groundbreaking language model that combines the best of generative and rule-based AI to create agents that can be tailored to any business.
Yasmin Lukatz Angel · Atherton, California, United States
Yasmin Lukatz is the Founder and Executive Director of ICON. She attended Stanford Graduate School of Business.
Show more
Investment focus
  • Medical, Consumer, Wellness
  • Seed, Pre-Seed
  • Israel
Portfolio highlights
  • Annabella — The Electric Breast Pump that mimics a baby's tongue. This technology encourages the release of oxytocin and prolactin hormones, leading to a 50% increase in average milk production.
  • Arya — Arya is building the Couples Wellness category, poised to become the next billion-dollar cornerstone in the global wellness market.Couples are falling into routine and many are experiencing increased loneliness. While billions are spent on fitness, mindfulness, and sleep, emotional and physical intimacy is often neglected. We invest in swipingfor the right partner and then trying to fix it (or spend a fortune divorcing them)... but not much in between.Arya's AI concierge makes it radically easy for couples to invest in their relationship and love life, both inside and outside the bedroom - a crucial ingredient to a successful relationship.
  • PointFive — PointFive provides ongoing cloud cost savings by providing deeper detection and collaborative repair solutions that fit smoothly into teams' normal operations.
Raoul Stein Angel
Raoul joined Kreos in 1999 and over the last 12 years has built a highly active presence as the leading senior credit provider to high-growth companies in Israel, as well as supporting a wide range of transactions across Europe. Mr. Stein also plays a key role in the management and execution of Kreos's overall strategy.Before joining Kreos,Raoul was an associate with Apax Partners in Israel where he invested in services and high-growth technology businesses and corporate spin-offs. He also assisted the general partners in fund-related activities such as divestment of their funds' successes traded on NASDAQ, and in general fund-raising activities such as portfolio analysis, reporting and due diligence for the purpose of raising new funds.Prior to joining Apax Partners, Raoul was an associate with Friedman , Turbidy & Co, a New York-based financial advisory firm. Raoul assisted the managing partner in several refinancing and acquisition transactions. He was involved in a refinancing of asset-backed loans with a large glass maker in the US, representing the company in its efforts to refinance its debt with banking institutions. In addition he was involved in fund-raising for a US based cosmetics company in its expansion.Raoul studied law at Bar-Ilan University. He clerked at the firm of M. Porath & Co in Tel-Aviv and passed the Bar exams in Israel in 1993. After that he graduated in 1995 from Columbia Business School with an MBA.
Show more
Investment focus
  • Medical, Health Care, Therapeutics
  • Pre-Seed
  • Israel
Portfolio highlights
  • Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
Nir Greenberg Angel
Founder and CEO at Natural Intelligence.
Show more
Investment focus
  • Advice, Medical, Software
  • Angel, Pre-Seed
  • Israel
Portfolio highlights
  • Pery — Pery empowers primary care providers to deliver better mental health care, boost revenue, and reduce administrative burdens. Learn more.
  • Superfy — Superfy gets you an answer to any question from a relevant person, using superior AI for matching people.With Superfy getting answers is simple. You ask a question, and Superfy connects you in chat with another user who already knows the answer. If you want to know the weather or exchange rates - go to Google; if you want to know what’s it liketo work at Google - ask Superfy!Superfy’s Machine Learning algorithms (US utility patent-pending) replace traditional NLP methods to crack the challenge of analyzing unstructured User Generated Content across all verticals.We launched our public iOS beta last December, and the stats are promising: 87% of our users are asking questions, 46% of our users are answering questions - over 10x the industry standard!  Our users love Superfy, spending 9 minutes a day on the app, and calling it “cool”, “addictive”, “super-friendly” and “helpful” (rated 4.4 on the US Appstore).Download (iOS): https://apple.co/2CZ3HjI Or search Superfy on the App Store.Superfy was founded by Gil Schoenberg and Michal Tamir, a married couple with years of startup experience in Business, Marketing and mostly Product, both for B2C and B2B. Among our advisors is Avishai Abrahami, Wix Founder & CEO, who paved the way for Israeli B2C startups.
Lyndon Babtiste Angel
Lyndon Babtiste
Show more
Investment focus
  • mHealth, Blockchain, Health Care
  • Seed
  • Israel
Portfolio highlights
  • Proof Work — Proof puts patients medical data on a decentralized secure platform and ledger for personal ownership, interoperability and a lifetime history of care. For free. In two minutes your health data is secured on the blockchain. It's as easy as that.Our solution makes data more private and liquid costs less to administer and provides a real-timelifesaving flow of medical data.This same medical data becomes an intrinsic valuable digital passport arising from the users prerogative for permission-based access control.Rights can be granted or traded to either another patient, payer or provider such as doctor, insurer, hospital, pharmacy, nurse, caregiver, family or friend.
Edward Lando Angel · San Francisco, California, United States · 9 investments in the past 12 months
Edward Lando is the founder of Pareto Holdings. He previously worked at Horizons School of Technology as a co-founder. Edward Lando attended the Wharton School.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Funding Round
  • United States, France, United Kingdom
Portfolio highlights
  • Superscale AI — Superscale AI is a marketing services company that helps the users to create content in social media platform.
  • Hidden Studios — Hidden Studios develops and advertises Fortnite Creative games, with 100M+ plays monthly. The company collaborated with prominent brands and creators, including Skydance, Snoop Dogg, and CaseOh, to deliver engaging gaming experiences. Hidden Studios maintains an active presence on YouTube, sharing content related to their Fortnite Creativeendeavors.
  • Swish Robotics — Embodied Intelligence for the Home
Moshe Shoham Angel
Moshe Shoham
Show more
Investment focus
  • Medical, Health Care, Artificial Intelligence
  • Pre-Seed
  • Israel
Portfolio highlights
  • Predicta Med — Predicta Med is a decision support platform for early detection and intervention selection of autoimmune diseases. Our platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient'scare. A process which typically takes more than four years and at least four different doctors can be shortened significantly using our platform.
Alan Patricof Angel · New York, New York, United States
Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.
Show more
Investment focus
  • Financial Services, Finance, Health Care
  • Series A, Seed, Funding Round
  • United States, Kenya, Spain
Portfolio highlights
  • Leena AI — Leena AI is a Gen AI employee assistant that reduces IT, HR, Finance tickets. We guarantee 70% self-service ratio in the contract.
  • Racket — Let's make a racket.
  • Alpha Tau Medical — Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.
Robert Nelsen Angel · New York, New York, United States · 5 investments in the past 12 months
Robert Nelsen is a co-founder and a Managing Director of ARCH Venture Partners. He joined ARCH at its founding and played a significant role in the early sourcing, financing and development of more than 100 companies, including nineteen which have reached valuations exceeding $1 billion. His seed and early-stage investments include Illumina (ILMN);Alnylam Pharmaceuticals (ALNY); Juno Therapeutics (JUNO); Unity Biotechnology (UBX); Sienna Biopharmaceuticals (SNNA); Vir Biotechnology, Agios Pharmaceuticals (AGIO); Sage Therapeutics (SAGE); GRAIL, Ikaria; Kythera Biopharmaceuticals (KYTH), Receptos (RCPT); Aviron (AVIR); Denali Therapeutics (DNLI); Rubius Therapeutics, KSQ Therapeutics, Beam Therapeutics, NetBot; Bluebird Bio (BLUE); R2 Technology; XenoPort (XNPT); Caliper Life Sciences (CALP); Trubion Pharmaceuticals (TRBN); Adolor (ADLR); deCODE Genetics; Array BioPharma (ARRY); Editas (EDIT), IDUN Pharmaceuticals; Classmates.com; Hua Medicine; Fate Therapeutics (FATE); WuxiNextCODE; and Everyday Learning Corporation.Mr. Nelsen is a director of Vir Bio, GRAIL, Sienna Biopharmaceuticals, Beam Therapeutics, Unity Biotechnology, Denali Therapeutics, Arivale, Syros Pharmaceuticals, and serves as Chairman of Hua Medicine, among others. He previously served as a Trustee of the Fred Hutchinson Cancer Research Institute, the Institute for Systems Biology, and was a director of the National Venture Capital Association. Mr. Nelsen holds an M.B.A. from the University of Chicago and a B.S. from the University of Puget Sound with majors in Economics and Biology.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Series C
  • United States, China, Israel
Portfolio highlights
  • Gameto — Gameto is a new breed of biotechnology company in female reproductive longevity
  • Katalyst — With one strength training session, you'll get a full-body workout in 20 minutes, with no external loads or joint impact. The Katalyst Training System uses low frequency impulses to stimulate and contract up to 90% of the muscle fibers in your body, for an intense workout equivalent to spending 2+ hours in the gym.
  • Colossal Biosciences — Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.
Lily Sarafan Angel · San Francisco, California, United States
Lily Sarafan is the Executive Chair of TheKey. She is also an Operating Partner at Cota Capital.An active Stanford alum, Lily serves on the Stanford Alumni Association Board of Directors, the Freeman Spogli Institute Council, and the Stanford Undergraduate Education Cabinet. She is also Founding Partner of Project BIG: The Stanford Brain ImmuneGut Initiative. Lily's board service extends to other high-impact nonprofits including the Women's Alzheimer's Movement and the BerkeleyHaas Center for Innovation Economies, where she is board chair. An appointee to the California Governor’s Alzheimer's Task Force, Lily serves in various leadership roles to advance economic development, civic engagement, and precision health.Lily holds an M.S. in Management Science and Engineering and B.S. in Science, Technology, and Society from Stanford University, where she was Eben Tisdale Fellow and Class President. She has been named Ernst & Young Entrepreneur of the Year, Women Health Care Executives Woman of the Year, and a Silicon Valley 40 Under 40. Lily is a Member of Young Presidents' Organization, a Term Member of the Council on Foreign Relations, a Henry Crown Fellow of the Aspen Institute, and a World Economic Forum Young Global Leader.
Show more
Investment focus
  • Health Care, Wellness, Enterprise Software
  • Seed, Funding Round, Series A
  • United States, Israel
Portfolio highlights
  • Seniorly — Seniorly helps families and older adults find the right senior living for their needs and budget. Combining the power of machine learning with the high-touch support of a national network of local advisors, Seniorly is modernizing senior living discovery. Through its online platform, Seniorly provides access to thousands of senior livingcommunities, expert insights, and personalized recommendations based search preferences. Seniorly also has a growing marketplace of trusted companies, offering other services and products that are helpful to families at this stage of life. Founded in 2014, Seniorly currently supports over 5 million visitors every year on their senior living journey. Visit http://www.seniorly.com for more information.
  • January AI — January's AI health app analyzes thousands of data points to help you eat smarter and live healthier. Wear a CGM once, and January creates your "digital twin," and personalized health insights via your 24/7 AI health coach.
  • NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.
Brock Weatherup Angel · San Diego, California, United States
Brock Weatherup is the CEO/Founder of Metamorphosis Partners driving enterprise value through innovation in the $80B pet industry focused on the consumer. Brock was most recently the EVP of Strategic Innovation & Digital Experience at Petco. Previously he was CEO & CoFounder of PetCoach (acquired by Petco) - revolutionizing the PetHealth Care experience. Brock is a CEO, entrepreneur, angel investor, builder of enterprise value and passionate advocate about the consumer and their interactions with digital media & Ecommerce. Brock is also managing partner of Atai Ventures angel investments, co-founder of ICONYC (www.iconyclabs.com) an early stage NYC based Israeli accelerator, investor/advisor/board member for 7+ startups - VeryApt, SideCar, Social Ladder, Ethology and an industry advisor for VC firms EQT Partners, MissionOG & SafeGuard. Previously Brock was SVP/Chief Digital Officer of Petsmart after selling Pet360 where he was CEO the prior 5 years. Brock was also CEO of Fathead and held several leadership positions with InterActiveCorp (Ticketmaster, Match.com, CitySearch, ReserveAmerica). A graduate of University of Colorado Boulder, sits as a board member of the Nature Conservancy – Adirondacks, father of two amazing girls and pet owner to my 4yr old retriever named...Boulder.
Show more
Investment focus
  • EdTech, Medical, mHealth
  • Seed
  • Israel, United States
Portfolio highlights
  • Myndlift — Myndlift offers a therapist-guided home neurofeedback solution for mental health, using mobile and wearable technology. Home users enjoy accessible and affordable training while neuro-therapists can grow their practices with remote supervision.
  • Amplio — Discover Amplio's innovative platform for speech-language and dyslexia interventions. Streamline educator workloads with evidence-based programs and real-time progress monitoring, ensuring every student receives the individualized support they need.
Lewis Pell Angel · Horsham, Pennsylvania, United States
Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry.
Show more
Investment focus
  • Health Care, Medical, Therapeutics
  • Funding Round, Post-IPO Equity
  • Israel, United States
Portfolio highlights
  • Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
  • Vision Sciences — Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes,otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.
Shahar Tzafrir Angel
Shahar is a Managing Partner at TLV Partners I, II, III. Shahar is a board member in Aidoc, Buildots, Canopy Immuno-Therapeutics, Deepcure, EverAfterAI, Granulate, Guesty, Hunterz, Immunai, Odo, ScyllaDB, Shookit, Silverfort.Before joining TLV Partners Shahar was a General Partner at Magma Venture Partners III and IV and was a board member inAidoc, Applitools, CloudEndure (acquired by Amazon), Coretigo, Guesty, Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, Tonkean
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Israel, United States
Portfolio highlights
  • Aidoc — Powered by an exclusive aiOS, Aidoc is trusted by 1,000+ hospitals to support physician decision-making at all points of care. See how our connected system of intelligence works.
  • Buildots — Buildots specializes in transforming construction sites into a data-driven digital environment. Its platform enables maximum control of construction processes at minimal effort. The solution turns every site walk into valuable process data that can immediately be used for gaining full control of a certain project.
  • DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
Ron Sabar Angel
Dr. Ron Sabar, founder and CMO of Sabar Health.
Show more
Investment focus
  • Health Care, Bioinformatics, Personal Health
  • Seed
  • Israel
Portfolio highlights
Nir Kalkstein Angel · Kfar Malal, HaMerkaz, Israel
Nir Kalkstein is an entrepreneur, a data scientist and a recognized expert in Big Data and machine learning algorithms. Nir co-founded Final, one of the most successful algo-trading companies worldwide. In 2009 He co-founded Medial with the vision of creating data-driven best-in-class predicative tools that provide physicians with actionableinsights to save lives. Nir has devoted significant intellectual and financial resources to support the ongoing success of the research for the Company, initially as the sole financier, and is committed to reinvesting his future profits into further research. Nir holds a BSc in Electrical Engineering from the Israeli Technion Institute of Technology.
Show more
Investment focus
  • Machine Learning, Health Care, Artificial Intelligence
  • Seed, Series B
  • Israel
Portfolio highlights
  • Nucleai — Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.
  • Medial EarlySign — Medial EarlySign develops an AI algorithmic platform for the discovery of clinical insights that indicate the likelihood of disease from basic medical information, such as blood test results, and other EMR data. Called AlgoMarkers, its predictive engines are built in collaboration with healthcare organizations, through the combination of 10s ofmillions of patient years-worth of data, clinical rigor and some of the most brilliant algorithmic minds. The company develops clinical decision support and population health solutions that can assist in the early prediction of clinical outcomes related to cancers, metabolic, immune and infectious diseases. These tools are designed to place at the fingertips of healthcare organizations only those insights that could prove critical in disease management and prevention empowering them with proactive, predictive and personalized care management capabilities
Mori Arkin Angel
Mori Arkin is one of Israel's most successful Life Science entrepreneurs. He is the Chairman and founder of Accelmed, a leading medical device investment firm. Mr. Arkin was the principal shareholder and Chairman of Agis Industries (1983) Ltd from its establishment until its merger with Perrigo in 2005. Agis, one of the leading genericpharmaceutical companies in Israel, merged with the US- based Perrigo in March 2005 in a $850 million transaction. Mr. Arkin has a degree in Psychology and Philosophy from Tel Aviv University (Israel).
Show more
Investment focus
  • Men's, Medical, Health Care
  • Seed
  • Israel
Portfolio highlights
  • Butterfly Medical — Butterfly, Butterfly Medical, BPH Treatment, BPH Office Procedure, Idan Geva, Minimally Invasive BPH, Prostate, Enlarged Prostate, Bening Prostate Hyperplasia, Urology
Ariel Yaar Angel · Los Angeles, California, United States
Ariel Yaar - VP Research and Development @ Readz
Show more
Investment focus
  • Software, Health Care, CRM
  • Seed, Series A, Series B
  • Israel, United States, United Kingdom
Portfolio highlights
  • GearEye — Gear Eye: the ultimate tracking solution for your gear. Manage and locate your equipment tagged with battery-free RFID tags and stickers. Never lose your items.
  • DermaDetect — DermaDetect was co-founded a year ago by four experienced entrepreneurs and is clinically led by Prof. Arieh Ingber, former head of department of dermatology in Hadassa Medical Center in Israel, a world-renowned dermatologist.We've developed a diagnostics & treatment tool/app (Apple, Android, Web), which enables healthcareprofessionals and patients to self-triage & manage skin disorders. The underlying technology is based on the combination of two approaches: dermatological rule base inference & image analysis using machine learning.We’re in a progress of a pilot-study to validate the effectiveness of our technology within the Israeli Health system, which is world’s best sandbox for such a study.Funded by two angel investors, eHealth Ventures [and their partners: Maccabi Healthcare Services in Israel (second biggest HMO in Israel), the Cleveland Clinic (the second largest healthcare provider in the US), Amgen], and supported by the Israel Innovation Authority.
  • BioChange Ltd. — BioChange has developed a breakthrough technology for tissue regeneration.
Sacha Levy Angel · New York, New York, United States
HealthTech angel
Show more
Investment focus
  • Software, Health Care, mHealth
  • Seed, Debt Financing
  • United States, Israel
Portfolio highlights
  • Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
  • ActiveProtective
  • Photosonix Medical — Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists andprimary care physicians.Photosonix Medical is based in Ambler, Pennsylvania.
Larry Ellison Angel · Redwood Shores, California, United States
Larry Ellison is executive chairman of Oracle Corporation and chief technology officer. He founded the company in 1977 and served as CEO until September 2014. He also races sailboats, flies planes, and plays tennis and guitar.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Series C, Series G
  • United States, Spain, Israel
Portfolio highlights
  • Imagene AI — Imagene AI is democratizing precision medicine with multi-modal foundation models and an end-to-end OI Suite. Our living intelligence engine integrates imaging, molecular, and clinical data to make every trial more responsive, every insight more actionable, and every patient journey more personalized.
  • Kosmos Tennis — Kosmos Tennis is pleased to announce the launch of www.daviscupfinals.com, which will be operational as of 22nd January, to keep the public informed about all aspects of the new Davis Cup Finals. The new website provides easy and intuitive access to all aspects of the new competition format, especially the finals, which will bring 18 national teamstogether in the same city over the course of a week. The new website will also report on the most significant events of the qualifiers set to take place in February.
  • Quark Pharmaceuticals — Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the “BiFAR” technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for theoccurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.
Zohar Zisapel Angel · Tel Aviv, Tel Aviv, Israel
Zohar Zisapel
Show more
Investment focus
  • Cyber Security, Information Technology, Security
  • Series A, Seed, Series B
  • Israel, United States
Portfolio highlights
  • Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
  • Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
  • Hailo — Hailo have developed the best performing AI processors for edge devices. Our AI accelerator chips are used for Smart City & Homes, machine learning, automotive AI, retail AI and smart factory Industry 4.0 solutions.
Nadav Lurie Angel
Nadav Lurie is the Employee at LURIE PROJECTS.
Show more
Investment focus
  • Consulting, Health Care, Professional Services
  • Series A
  • Israel
Portfolio highlights
  • Droxi — Droxi is an AI-based platform that helps primary care physicians to reduce the amount of time spent on non-patient-facing tasks.
Anne Wojcicki Angel · San Francisco, California, United States · 2 investments in the past 12 months
Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Series B
  • United States, United Kingdom, Canada
Portfolio highlights
  • World Labs — World Labs is an AI startup that can analyze visual data with comprehension akin to a person's, a substantial advancement above existing capacities.
  • Solace — Connect with expert patient advocates who can help you navigate the healthcare system and solve any medical problem, no matter what you need.
  • Endo Health — Reverse Your Diabetes With a Game
Tamara Minick-Scokalo Angel · Lausanne, Vaud, Switzerland
Tamara Minick-Scokalo, Non-Executive Director at Avast.
Show more
Investment focus
  • Farming, Software, Wellness
  • Seed
  • Israel, United States
Portfolio highlights
  • Alora — Agrisea is an ocean agriculture company building the technology of today to bring peace tomorrow. The company solution genetically fortifies their crops so that they may grow in the oceans, similar to hydroponics. They create a cellular cycle of original and independent genes to promote a system that works together, rather than alone, distributingthe pressure of saltwater over a more capable group of genes.Agri design mimics nature and recreates these natural effects using the genetic material already found in their land crops. Their farms are designed with spatial optimization and a hydroponic basis in mind, wave motion is mitigated and the plant roots are positioned to absorb the necessary nutrients directly from the surrounding saltwater.
  • NeuraLight — NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care.
Avishai Abrahami Angel · New York, New York, United States
Avishai Abrahami is our Co-Founder, has served as our Chief Executive Officer since September 2010 and was our Co-Chief Executive Officer and a director since October 2006. From 2004 to 2006, Avishai was the Vice President of Strategic Alliances at Arel Communications & Software Ltd., a private Israeli company specializing in communicationtechnology. In 1998 he co-founded Sphera Corporation, a private company which develops software for managing data centers, and he served as its Chief Technology Officer from 1998 until 2000 and its Vice President of Product Marketing from 2000 until 2003. In 1993, he co-founded AIT Ltd., a private Israeli software company, and served as its Chief Technology Officer until the company's sale in 1997. Avishai served in the Israeli Defense Forces' elite computer intelligence unit from 1990 until 1992.
Show more
Investment focus
  • Software, Apps, Social Media
  • Seed, Series A, Pre-Seed
  • Israel, United States, Italy
Portfolio highlights
  • Affogata — Affogata optimizes the digital customer journey by analyzing customer interactions and identifying customer needs in real-time.
  • The Gist — The Gist for Slack is our first app to manage your work information overload. Get the gist of it with our personalized AI enginge.
  • Unlimited Robotics — Unlimited Robotics empowers developers to build apps on Gary, the perfect robot for your business or office, and make any robot into a multipurpose one with Ra-Ya.
Oren Zeev Angel · San Francisco, California, United States · 4 investments in the past 12 months
Oren Zeev is the Founder of and one of the two main early backers respectively, a former board member of Zeev lives in San Francisco, California, United States.
Show more
Investment focus
  • Software, Internet, FinTech
  • Series A, Series B, Seed
  • United States, Israel, Canada
Portfolio highlights
  • Linguana — Linguana builds and monetizes your fully localized YouTube channels in new languages to reach new audiences across the globe and monetize them.
  • Fairmatic — Powered by data and AI, focused on rewarding fleet safety with savings. Finally, a smarter insurance option designed to put fleets in control.
  • Riverside — Riverside.fm makes it easy for podcasters and media companies to record remote interviews in studio quality. End result? 4k video and WAV audio content.
Eyal Gura Angel
Eyal Gura is the Board Member of Imagene AI. He previously worked at Zebra Medical Vision Ltd as a Co-Founder, President and Chairman of the Board. Eyal Gura attended Reichman University (IDC Herzliya).
Show more
Investment focus
  • Software, Mobile, Artificial Intelligence
  • Series A, Seed, Series B
  • United States, Israel, Belgium
Portfolio highlights
  • Theator — Discover the world's first surgical intelligence platform from theator. Continually perfect your craft with AI & computer vision technology.
  • Taranis — Taranis offers cutting-edge crop & farm management software for precision agriculture. Increase efficiency and yield. Learn more now.
  • Imagene AI — Imagene AI is democratizing precision medicine with multi-modal foundation models and an end-to-end OI Suite. Our living intelligence engine integrates imaging, molecular, and clinical data to make every trial more responsive, every insight more actionable, and every patient journey more personalized.
Investors by industry
Investors by country
Angel Investors in Israel by industry